Stenotrophomonas maltophilia,an emerging pathogen in newborns:Three case reports and a review of the literature  

作　　者：Bijaylaxmi Behera 

机构地区：[1]Department of Pediatrics&Neonatology,Chaitanya Hospital,Chandigarh 160044,India

出　　处：《World Journal of Clinical Infectious Diseases》2021年第1期11-18,共8页世界临床传染病学杂志

摘　　要：BACKGROUND Stenotrophomonas maltophilia(S.maltophilia)is a rare cause of neonatal sepsis with significant morbidity and mortality and has extensive resistance to several antibiotics leaving few options for antimicrobial therapy.Only a few cases have been reported in neonates from developing countries.We report three cases of critically ill,extramural babies with neonatal S.maltophilia sepsis.All three babies recovered and were discharged.CASE SUMMARY All three cases were term extramural babies,who were critically ill at the time of presentation at our neonatal intensive care unit.They had features of multiorgan dysfunction at admission.Blood culture was positive for S.maltophilia in two babies and one had a positive tracheal aspirate culture.The babies were treated according to the antibiogram available.They recovered and were subsequently discharged.CONCLUSION Although various authors have reported S.maltophilia in pediatric and adult populations,only a few cases have been reported in the newborn period and this infection is even rarer in developing countries.Although S.maltophilia infection has a grave outcome,our three babies were successfully treated and subsequently discharged.

关 键 词：CEFTRIAXONE Multidrug resistant Neonatal sepsis Stenotrophomonas maltophilia COTRIMOXAZOLE TIGECYCLINE 

分 类 号：R72[医药卫生—儿科]